Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 75Se-Homocholic acid taurine scintigraphy (75SeHCAT®), a standard benchmark tes...
Journal Information
Vol. 38. Issue 5.
Pages 305-311 (September - October 2019)
Share
Share
Download PDF
More article options
Visits
12
Vol. 38. Issue 5.
Pages 305-311 (September - October 2019)
Special collaboration
75Se-Homocholic acid taurine scintigraphy (75SeHCAT®), a standard benchmark test in bile acid malabsorption?
Gammagrafía con 75Se-ácido tauroselcólico (75SeHCAT®), ¿prueba de referencia en la malabsorción de ácidos biliares?
Visits
12
A. Baena García
Corresponding author
alvaronuclear16@gmail.com

Corresponding author.
, F. Partida Palma, S. García Martínez, M. de Bonilla Candau, M. Pajares Vinardell
Servicio de Medicina Nuclear, Hospital Universitario Puerta del Mar, Cádiz, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (6)
Show moreShow less
Abstract

Chronic diarrhea due to bile acid malabsorption (BAM) is an underdiagnosed pathology. Different diagnostic tools are available. However, there is currently no consensus on which of these would be the benchmark test or gold standard. This review evaluates the possibility of using 75Se-taurocholic acid (75SeHCAT®) scintigraphy as a benchmark diagnostic test and its perspective for the future. A literature review was conducted in Pubmed and OVID obtaining a total of 57 papers, 26 of which were finally used after being selected under the concepts of gold standard, diagnostic accuracy and other biomarkers. We evaluated the advantages and disadvantages of the different diagnostic tools: 14C-glycocholate, measurement of bile acids in feces, C4 in serum, FGF19 in serum, cholestyramine, and 75Se-tauroselcolic acid scintigraphy. We consider that the 75SeHCAT® scan is the most recommended diagnostic test in Europe for diagnosing BAM as it presents the highest values of sensitivity and specificity. It has a significant cost–benefit ratio, making it the test with the highest degree of recommendation. However, it is still not possible to use it in a recognized way as a gold standard due to the lack of studies that provide conclusive data that allow consensus. In the meantime, the combined use of cholestyramine testing in all patients we want to evaluate, regardless of the scintigraphy result, could be encouraged as a benchmark standard.

Keywords:
75SeHCAT®
Bile acid malabsorption
Chronic diarrhea
Cholestyramine
C4
Resumen

La diarrea crónica por malabsorción de ácidos biliares (MAB) es una patología infradiagnosticada. Se dispone de diferentes herramientas diagnósticas, aunque en la actualidad no existe consenso sobre cuál de estas sería la prueba de referencia o gold standard. En esta revisión se valora la posibilidad de utilizar la gammagrafía con 75Se-ácido tauroselcólico (75SeHCAT®) como prueba diagnóstica de referencia y su perspectiva de futuro. Se realizó una búsqueda bibliográfica en Pubmed y OVID, obteniéndose un total de 57 trabajos y usándose finalmente 26 de ellos tras ser seleccionados bajo los conceptos de gold standard, exactitud diagnóstica y otros biomarcadores. Valoramos las ventajas e inconvenientes de las diferentes herramientas diagnósticas: 14C-glicocolato, medición de ácidos biliares en heces, C4 en suero, FGF19 en suero, colestiramina y gammagrafía con ácido tauroselcólico. Consideramos que la gammagrafía con 75SeHCAT® es la prueba diagnóstica más recomendada en Europa para el diagnóstico de MAB al presentar los índices más elevados de sensibilidad y especificidad. Presenta una gran relación coste-beneficio, por lo que es la prueba con mayor grado de recomendación. Sin embargo, aún no es posible su uso de forma reconocida como gold standard debido a la falta de estudios que proporcionen datos concluyentes que permitan su consenso. Mientras tanto, se podría aconsejar el uso combinado de la prueba con colestiramina en todos los pacientes que queramos evaluar, independientemente del resultado gammagráfico, como uso de patrón de referencia.

Palabras clave:
75SeHCAT®
Malabsorción de ácidos biliares
Diarrea crónica
Colestiramina
C4

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos